TRAINM: Providing personalised therapy for the disabledJune 17, 2016
About the companyTRAINM is Europe's most innovative neuro-rehabilitation clinic. They deliver measurable recoveries and aim to help people with neurological deficits, even when they have been told no recovery was possible. KOIS invested in TRAINM in 2016, believing in its innovative and comprehensive approach to neuro rehabilitation.
TRAINM's inception year
KOIS investment year
Targets children and adults suffering from neurological and orthopedic disabilities
Active in Belgium
Compassionate care focused on physical, social and mental wellness
Specialists state that up to 1 in 3 Europeans will suffer at least once in their lifetime from a disease affecting the neurological system. This leads to great human suffering and restricts the independence of those suffering from these diseases as a result of disability and the need for care.
TRAINM is an outpatient neuro-rehabilitation clinic for children and adults with a broad range of neurological and orthopaedic disabilities. Therapy is based on neuroplasticity, reducing neurological deficits from injuries to the brain and spinal cord. Patients receive on average 1,000 movements per session, 20 times more than con- ventional physical therapy.
Patients who do not have the financial means to receive outpatient treatment at TRAINM may be eligible to receive assistance from the TRAINM Foundation.
In 2016, KOIS invested in TRAINM because of its potential to offer life-changing therapy to people who otherwise would not have a viable chance of recovery. Initiatives like TRAINM bridge the gap between discoveries made in research laboratories and the patients’ needs.
Note: Last updated April 2020
Discover our other projects
Impact Expansion: investing to tackle social exclusion, healthcare challenges and climate change in Europe
Impact Expansion was founded in 2022 through a covenant of partners from KOIS and Milestone. On the strength of their expertise in impact investing with a strong buy-and-build track record, the fund invests in companies during their growth stage in 3 focus sectors: Healthcare, Education & Employment, and Environment.
KOIS and Quadria capital co-founded HealthQuad in 2016. Since then,
HealthQuad has become India’s leading Healthcare Focused Venture Capital Fund. The fund typically invests in early stage companies with a high disruption potential in the healthcare industry. HealthQuad aims to contribute to improving affordability, accessibility and quality of healthcare services in India while generating attractive returns for investors.
European Union Member States have been confronted with the challenge of unemployment for several decades with relatively similar characteristics. Seeking innovative approaches to tackle this common issue, KOIS has supported the European Investment Advisory Hub (EIAH), in testing the preliminary feasibility of a Pan-European Social Outcomes Contracting (SOC) scheme. In this study, we explore the potential benefits and hurdles of a multi country Social Outcomes Contracting in three pilot countries, France, Belgium and the Netherlands.